关于里希特综合症治疗的最新情况,包括新的组合方法
1Division of Hematology-Oncology, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Cancers
|March 28, 2025
概括
里希特综合征 (RS),慢性淋巴细胞白血病 (CLL) 的转变,呈现出不良预后和诊断挑战. 新的治疗方法对治疗这种侵袭性淋巴瘤有前途.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 里希特综合征 (RS) 是慢性淋巴细胞白血病 (CLL) 转化为攻击性淋巴瘤,通常是扩散性大B细胞淋巴瘤 (DLBCL).
- 复发性脊髓炎的预后不佳,在临床鉴定和治疗方面带来了重大挑战.
- 与非相关病例相比,与克隆相关的RS显示出更糟糕的预后,与De novo DLBCL不同的基因组配置文件.
研究的目的:
- 审查当前关于里希特综合征病理学,诊断和管理的文献.
- 突出了解和治疗CLL这种侵略性转变的挑战和进展.
主要方法:
- 对现有的科学文献进行全面的审查.
- 对RS病理特征,诊断标准和治疗策略的分析.
- 对最新和正在进行的关于新型治疗方式的研究进行评估.
主要成果:
- DLBCL-RS的基因组概况不同于新的DLBCL.
- 化学免疫疗法是历史上的护理标准,干细胞移植提供了更好的反应耐久性.
- 最近对组合疗法的研究,包括免疫检查点抑制剂和向疗法,产生了不同的结果.
- 新兴疗法,如双特异性抗体,CAR T细胞疗法和抗体-药物联合体正在积极评估中.
结论:
- 里希特综合征仍然是一个难以管理的血液恶性瘤.
- 了解转化病理学的进步至关重要.
- 对新型治疗策略的持续研究为改善患者治疗结果提供了未来的希望.
更多相关视频
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications